Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.3M Buy
+1,588,800
New +$41.6M 0.08% 205
2025
Q4
– Sell
-1,000
Closed -$25.5K – 3257
2025
Q3
$25.5K Sell
1,000
-12,300
-92% -$304K ﹤0.01% 2725
2025
Q2
$322K Buy
13,300
+800
+6% +$18.7K ﹤0.01% 2296
2025
Q1
$317K Sell
12,500
-94,100
-88% -$2.46M ﹤0.01% 2258
2024
Q4
$2.83M Buy
+106,600
New +$2.89M 0.01% 1223

Other funds holding PFE

PEAK6's PFE Position: Q2 2026 in Review

PEAK6 opened a new position in Pfizer (PFE) in Q2 2026: 75,818 shares worth $1.83M. The stake represents ﹤0.01% of the portfolio and ranks #1375 among its holdings. This is a return to the name: PEAK6 previously reported a position in PFE as recently as Q4 2025.

PEAK6 first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • PEAK6 held 75,818 shares of Pfizer worth $1.83M as of Q2 2026.
  • Pfizer was a new PEAK6 position in Q2 2026.
  • Pfizer made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #1375 holding.
  • PEAK6 first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.